Content by Weill Cornell Medicine
Weill Cornell develops engineered mycobacteria with kill switches for safer TB vaccine trials, a breakthrough in tuberculosis research
| 3 min read
Half of patients treated with a combination of immune checkpoint inhibitors survive cancer-free for 10+ years
| 3 min read
Researchers used advanced methods to show how certain lipids interact with pacemaker ion channels
| 3 min read
Page 1 of 1 - 3 Total Items
